Edition:
United Kingdom

Collplant Biotechnologies Ltd (CLGN.OQ)

CLGN.OQ on NASDAQ Stock Exchange Capital Market

5.00USD
20 Jun 2019
Change (% chg)

-- (--)
Prev Close
$5.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,264
52-wk High
$8.73
52-wk Low
$3.13

Latest Key Developments (Source: Significant Developments)

Collplant Announces Corporate Name Change To Collplant Biotechnologies To Better Reflect Its Business
Thursday, 20 Jun 2019 

June 20 (Reuters) - Collplant Holdings Ltd ::COLLPLANT ANNOUNCES CORPORATE NAME CHANGE TO COLLPLANT BIOTECHNOLOGIES TO BETTER REFLECT ITS BUSINESS.COLLPLANT HOLDINGS - ITS CORPORATE NAME HAS CHANGED TO "COLLPLANT BIOTECHNOLOGIES LTD." EFFECTIVE ON OPENING OF TRADING ON JUNE 21.COLLPLANT HOLDINGS LTD - COMPANY'S ADSS WILL CONTINUE TRADING ON NASDAQ CAPITAL MARKET UNDER SAME TICKER SYMBOL "CLGN".  Full Article

Collplant Reports Fourth Quarter And Year End 2018 Financial Results And Provides Business Update
Monday, 1 Apr 2019 

Collplant Holdings Ltd ::COLLPLANT REPORTS FOURTH QUARTER AND YEAR END 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.COLLPLANT HOLDINGS LTD - Q4 REVENUES OF $4.2 MILLION WITH NET INCOME OF $1.0 MILLION.COLLPLANT HOLDINGS LTD - COMPANY POSTED Q4 COMPREHENSIVE INCOME OF $0.004 (NIS 0.02) PER SHARE.  Full Article

Ami Sagy Reports 23.2 Pct Stake In Collplant Holdings
Monday, 11 Feb 2019 

Feb 11 (Reuters) - Collplant Holdings Ltd ::AMI SAGY REPORTS 23.2 PERCENT STAKE IN COLLPLANT HOLDINGS AS OF DECEMBER 31, 2018 - SEC FILING.AMI SAGY SAYS ACQUIRED ORDINARY SHARES OF COLLPLANT HOLDINGS FOR INVESTMENT PURPOSES ONLY.  Full Article

Collplant Reports Q1 Non-GAAP Loss Per Share $0.01
Thursday, 24 May 2018 

May 24 (Reuters) - Collplant Holdings Ltd ::COLLPLANT REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 REVENUE ILS 779,000.Q1 NON-GAAP LOSS PER SHARE $0.01.  Full Article

CollPlant Q4 Revenue Rose 375 Percent To ILS 952,000
Wednesday, 21 Mar 2018 

March 21 (Reuters) - Collplant Holdings Ltd ::COLLPLANT REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q4 REVENUE ROSE 375 PERCENT TO ILS 952,000.Q4 LOSS PER SHARE $0.01.  Full Article

CollPlant receives innovation authority approval for R&D Program
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Collplant Holdings Ltd :Says received Ministry Of Economy Innovation Authority's approval for Collplant's research and development program for 2017​.  Full Article

No consensus analysis data available.